Platelet Study Guide

Platelets (Chapter 13)

Description

  • Smallest blood cells.
  • Anucleated (no nucleus) with granulated cytoplasm.
  • Consists of granular cytoplasm with a membrane but no nuclear material; granules are important for coagulation.
  • Diameter: 2.5μm2.5 \mu m
  • MPV (Mean Platelet Volume): 8 to 10 fL
  • Shape: Biconvex when circulating and resting; becomes round in EDTA.
  • Blood film: Circular to irregular, lavender, and granular (darker reddish-violet).
  • Cluster with RBCs near the center of the blood vessel.
  • Move laterally with WBCs into the white pulp of the spleen for sequestration (1/3 of platelets).
  • Normal count: 150×109/L150 \times 10^9/L to 400×109/L400 \times 10^9/L (two-thirds circulate).
  • Under hemostatic need, platelets become irregular and sticky, extending pseudopods and adhering (to blood vessels) and aggregating (attaching to each other).
  • Splenomegaly leads to Thrombocytopenia.
  • Splenectomy leads to Thrombocytosis.
  • Reticulated platelets or Stress platelets:
    • Cause: Severe thrombocytopenia.
    • Size: Markedly larger.
    • Diameter: >6 \mu m
    • MPV: 12 to 14 fL
    • Citrated whole blood: Cylindrical and beaded.
    • Carry free ribosomes and fragments of RER.
    • Signals early and rapid release.
    • Stain: Thiazole orange

Platelet Size and Appearance

  • Size: 2-4µm
  • Nucleus: NA
  • Cytoplasm: Light blue to colorless
  • Granules: red to violet, abundant (darker = more granules)
  • N/C Ratio: NA
  • Reference Interval
    • Bone Marrow: NA (megakaryocytes only)
    • Peripheral Blood: 7-25 per 100x OIF (1000x magnification)
  • Small compared to RBC & WBC
  • Removal
  • Early reticulocyte
  • Stress reticulocytes or shift reticulocytes
  • In shape

Ultrastructure of Resting Platelet

Plasma Membrane
  • Phospholipid bilayer; selectively permeable
Lipids
  1. Phospholipid

    • Phosphatidylcholine and sphingomyelin – neutral; outer plasma layer
    • Phosphatidylinositol, phosphatidylethanolamine, and phosphatidylserine – anionic; polar; inner cytoplasmic layer; PI (arachidonic acid); PS (flips; coagulation factors assemble)
PhospholipidChargeLocationFunction
Phosphatidylcholine (PC)neutralouter
Sphingomyelin (S)neutralouter
Phosphatidylinositol (PI)anionicinnerArachidonic acid
Phosphatidylethanolamine (PE)anionicinner
Phosphatidylserine (PS)anionicinnerFlips (flippase); coagulation factors assemble
  1. Cholesterol

    • Stabilizes the membrane.
    • Maintains fluidity.
    • Helps control passage of material.
    • Location: fatty acid tails, in hydrophobic region
Glycoproteins and Proteoglycans
  • Within the membrane
  • Support surface glycosaminoglycans, oligosaccharides, and glycolipids
Membrane Surface (Glycocalyx)
  • Glycocalyx – carbohydrate coat; has sialic acid (-)
  • Absorbs albumin, fibrinogen, and other plasma proteins (+)
  • Glycocalyx + plasma proteins = stick to each other
  • Thicker than RBC and WBC
  • Adhesive
  • Negative surface charge
Surface-Connected Canalicular System (SCCS)
  • Unique structure only in platelets
  • Plasma membrane invades the platelet interior
  • Twists enabling platelets to store additional quantities of proteins
  • Route for endocytosis and for secretion of granular contents
Dense Tubular System (DTS)
  • Major structure: Majority of enzymes needed for platelet activation and calcium are all stored in the DTS.
  • Parallel and closely aligned to the SCCS
  • Condensed remnant of RER
  • Sequesters Ca2+Ca^{2+} and bears a series of enzymes that support platelet activation (phospholipase A2, cyclooxygenase, thromboxane synthase, phospholipase C)
  • Control center for platelet activation (and calcium storage)
Plasma Membrane Receptors for Adhesion
  • Found in outer surface
  • Cell adhesion molecule (CAM) family
    • CAM integrin family
    • CAM leucine-rich repeat family
    • CAM immunoglobulin gene family
    • CAM selectin family
  • Seven-transmembrane receptor (STR) family
  • Integrins bind collagen to enable platelets to adhere to injured blood vessel (GP – glycoprotein)
    • GP Ia/IIa (α<em>2β</em>1\alpha<em>2\beta</em>1) – collagen (GP VI, IV)
    • GP Ic/IIa (α<em>5β</em>1\alpha<em>5\beta</em>1) – laminin
    • GP Ic/IIa (α<em>6β</em>1\alpha<em>6\beta</em>1) – fibronectin
    • GP Ib/IX/V (1b95): Major receptor for cell adhesion
    • GP IIb/IIIa (α<em>2β</em>3\alpha<em>2\beta</em>3): Major receptor for platelet aggregation
  • Integral protein/transmembrane proteins
    • Those that span the entire membrane
  • Peripheral proteins/skeletal proteins
    • Proteins found in the inner side of the membrane
    • They provide shape and structure in the plasma membrane
  • Outer surface of the cell
    • Proteins + carbohydrates
    • GP - glycoprotein

Plasma Membrane Receptors for Activation: STRs

  • Thrombin
  • ADP (adenosine diphosphate)
  • Epinephrine
  • TXA2TXA_2 (thromboxane A2)
  • PAR – protease activated receptor
  • P2Y – purines

Additional Platelet Membrane Receptor

  • ICAMS (CD50, CD54, CD102) – inflammation and immune reaction
    • ICAMS – intercellular adhesion molecules
  • PECAM (CD31) – plt to WBC and plt to endothelial cell adhesion
    • PECAM – Platelet endothelial cell adhesion molecule
  • FcγRIIAFc\gamma RIIA (CD32) – HIT (Heparin-induced thrombocytopenia)
  • P-selectin (CD62) – plt adhesion and aggregation; stored in α-granules of plt

Platelet Cytoskeleton – Maintain Integrity

Microtubules
  • Skeletal framework
  • Maintain plt shape
  • Thick circumferential bundle
  • Disassemble at refrigerator temp. or with colchicine
  • Shape: Cylindrical
  • Contract on activation (Ca) releasing contents of α-granules (Secretion)
  • Reassemble to provide rigidity to pseudopods
  • Flexible; disassembles when plt is activated
Microfilaments
  • Composed of actin
    • Contractile; anchors glycoproteins and proteoglycans
    • Also present in cytoplasm
    • As calcium increases, actin contracts
Intermediate Filaments
  • Desmin and vimentin
  • Connect with actin and tubules, maintaining plt shape

NOTE: Contraction of microtubules and filaments when it encounters CALCIUM

Electrophoresis Nomenclature

CURRENT NOMENCLATURENEW NOMENCLATURELIGAND
GP Ia/IIaα<em>2β</em>1\alpha<em>2\beta</em>1Collagen
α<em>Vβ</em>1\alpha<em>V\beta</em>1Vitronectin
α<em>5β</em>1\alpha<em>5\beta</em>1Laminin
α<em>6β</em>1\alpha<em>6\beta</em>1Fibronectin
GP VICAM of the immunoglobulin gene familyCollagen
GP Ib/IX/VCAM of the leucine-rich repeat familyVWF and thrombin bind GP Iba; thrombin cleaves a site on GP V
GP IIb/IIIaαIIbβ<em>3/α</em>2β3\alpha IIb\beta<em>3 / \alpha</em>2\beta_3Fibrinogen, VWF
  • “Agonists”
  • activate platelets
  • ligands for STRs

Platelet Granules

α-Granules
  • Most abundant
  • 50 to 80 in each plt (small in size)
  • Stain medium gray with osmium
  • Filled with proteins (endocytosed thru SCCS; synthesized in megakaryocytes; membrane-bound)
  • When plts activate, granule membranes fuse with SCCS (excreted) and contents flow
  • Route of secretion: SCCS
  • Majority of contents – coagulation proteins
Gray Platelet Syndrome
  • Inherited absence of α-granule contents; giant
  • Membranes and membrane-bound proteins are present
  • Soluble proteins within are missing
  • Plts appear large and light gray (Wright stain)
  • Diminished response to ADP, collagen, epinephrine and thrombin
  • Mucocutaneous bleeding (under skin, mucosal surfaces; ex: nosebleed, menorrhagia)
δ-Granules
  • a.k.a dense bodies
  • 2 to 7 per plt
  • Stain black with osmium
  • Stores endocytosed molecules
  • Migrate to the plasma membrane and release their contents
  • Route of secretion: Plasma membrane
Storage Pool Disorder
  • Diminished δ-granule contents
  • Inherited diseases characterized by albinism (e.g. Hermansky-Pudlak syndrome)
  • Does not affect morphology
  • Failure to secrete when treated with thrombin
Lysosomes
  • Have hydrolytic enzymes to clean up debris
  • Stain positive (+) for: arylsulfatase, β-glucuronidase, ACP, and catalase (enzymes)
  • Digest vessel wall matrix and autophagic debris

Processes Involved in Platelet Activation

  1. Adhesion
  2. Aggregation
  3. Secretion
Adhesion
  • Platelet to non-platelet (collagen)
  • Most common occurrence (minor injuries)
  • Plts reversibly bind elements of the vascular matrix
  • For repair of minor injuries to blood vessels
  • Veins or venules:
    • Plts adhere directly to collagen through GP Ia/IIa, GP IV and GP VI
  • Capillaries and arterioles:
    • Blood flow is more turbulent
    • First carpeted by VWF (mediator – strong protein as a bridge) which binds with collagen; after which, plts adhere (GP Ib/IX/V)
  • Require actin contraction and formation of pseudopods
  • Assessment:
    • Measurement of VWF activity
    • Quantitation of CAMs through flow cytometry

In normal blood vessels without injury, flow of blood is smooth and continuous.

3 functions of platelets; happen simultaneously

Normal ECM suppresses hemostasis:

  • Prostacyclin
  • Heparan sulfate
  • Tissue factor pathway inhibitor
  • Nitric oxide
  • Thrombomodulin
Aggregation
  • Platelet to platelet
  • Plts irreversibly bind each other
  • Extensive vessel damage
  • Requires active GP IIb/IIIa (binds RGD sequence of plasma proteins; fibrinogen & VWF)
    • RGD: Arginine-glycine-aspartic acid
  • Includes pseudopod formation and redistribution of P-selectin to surface membrane
  • PS flips to the outer layer
  • Membrane integrity is lost
  • Irreversible end point:
    • “white clot” / hyaline clot – inappropriate plt activation in arterioles and arteries (arterial thrombosis)
      • platelet-VWF plug (platelet + VWF)
    • “red clot” = Fibrin + RBCs; inappropriate coagulation in venules and veins (venous thrombosis)
  • Assessment:
    • Platelet aggregometry
    • Lumiaggregometry
Secretion
  • Activated plts release granular contents once squeezed or contracted
  • Trigger: Ligand binding integrins and STRs triggers actin contraction
  • Intermediate filaments and microtubules contract, compressing granules
  • α-granules and lysosomes: SCCS; some are coagulation factors
  • δ-granules: Plasma membrane; vasoconstrictors and plt agonists
  • PS flips outward: Tenase (Factor VIII & Factor IX, cleave Factor X) and prothrombinase (Factor X & Factor V, cleave Factor II – prothrombin) form supported by calcium secreted by δ-granules
  • Assessment:
    • Lumiaggregometry – most successful; firefly luciferase (make fireflies glow) to identify ATP (from δ-granules)
    • Assays for PF4 or β-thromboglobulin

Platelet Activation Pathways

G Proteins
  • All cells have this for platelet activation and intracellular communication & signaling.
  • Control cellular activation for all cells at the inner membrane surface
Eicosanoid Synthesis Pathway
  • Prostaglandin, cyclooxygenase, or thromboxane pathway (major enzymes involved)
  • Triggered by G protein
  • Major enzyme activated: Phospholipase A2
  • Deficiency: Platelet release disorder or Aspirin- like disorder
  • Corresponding Pathway in Endothelial cells:
    • thromboxane synthase → prostacyclin synthase
    • TXA<em>2TXA<em>2PGI</em>2PGI</em>2 (prostacyclin)
    • Prostacyclin: platelet inhibitor

cAMP sequesters calcium into DTS → decreased cAMP will cause Ca2+Ca^{2+} to go out of DTS → Ca2+Ca^{2+} released in cytoplasm → cause platelet activation

Inositol Triphosphate and Diacylglycerol
  • Second G protein-dependent pathway
  • From phosphatidylinositol
  • Major enzyme involved: Phospholipase C (PLC)
    • PLC breaks down phosphatidylinositol into 2 fragments: diacylglycerol (DAG) & inositol triphosphate (IP3)
  • DAG: activates phosphokinase → phosphorylate flextrin → cause direct actin contraction
  • IP3: causes release of Ca2+Ca^{2+} from DTS → platelet activation

Summary: Platelet Characteristics

Diameter2.5µm
MPV8 – 10 fl
Size2 – 4 µm
NucleusNA
CytoplasmLight blue to colorless
GranulesRed to violet, abundant
N/C RatioNA (no nucleus)
Reference interval (PB)7 – 25 per 100x OIF
Normal count150 – 400x 109/L10^9/L
ADHESION RECEPTORINTEGRINLIGAND
GP Ia/IIaα<em>2β</em>1\alpha<em>2\beta</em>1collagen
α<em>vβ</em>1\alpha<em>v\beta</em>1vitronectin
GP Ic/IIaα<em>5β</em>1\alpha<em>5\beta</em>1laminin
α<em>6β</em>1\alpha<em>6\beta</em>1fibronectin
GP VIImmunoglobulin famcollagen
GP Ib/IX/VLeucine-rich famVWF & thrombin
GP IIb/IIIaαIIbβ<em>3/α</em>2β3\alpha IIb\beta<em>3 / \alpha</em>2\beta_3fibrinogen & VWF
ReceptorFunctionDisorder
GP Ib/IX/VCell adhesionBernard-Soulier syndrome
GP IIb/IIIaPlatelet aggregationGlanzmann thrombasthenia
ACTIVATION RECEPTORLIGAND
PAR1Thrombin
PAR4
P2Y1ADP
P2Y12
TPαTP\alpha and TPβTP\betaTXA2TXA_2
α2\alpha_2 - adrenergicEpinephrine
IP (inositol triphosphate)PGI2PGI_2 (prostacyclin)
GranulesAbundanceRoute of Secretion
α-granules50-80 each pltSCCS
δ-granules2-7 each pltPlasma membrane
GranulesStained with osmiumDisorders
α-granulesMedium grayGray Platelet
δ-granulesblackStorage Pool
PLATELET ACTIVATION PROCESSES
ADHESIONAGGREGATIONSECRETION
Plt to non-pltPlt to pltRelease of granular contents
actin contraction, formation of pseudopodsGP IIb/IIIa binds to RGD sequenceLigand binding integrins & STRs
reversibleirreversibleirreversible
VWF activity, flow cytometryPlt aggregometry, LumiaggregometryLumiaggregometry
PLATELET ACTIVATION PATHWAYS
PATHWAYEICOSANOID
Major enzymePhospholipase A2